Current Biotechnology ›› 2026, Vol. 16 ›› Issue (4): 979-989.DOI: 10.19586/j.2095-2341.2025.0147
• Articles • Previous Articles
Yue LUO1(
), Xing JIANG1, Chao WANG1, Yingqiu WU1, Hongwei LUO1, Lu ZHANG2(
)
Received:2025-10-27
Accepted:2026-03-10
Online:2026-07-25
Published:2026-09-11
Contact:
Lu ZHANG
CLC Number:
Yue LUO, Xing JIANG, Chao WANG, Yingqiu WU, Hongwei LUO, Lu ZHANG. Mechanistic Study on Total Flavonoids from Hedyotis diffusa Willd. Inhibiting Lung Cancer Through the CDCA8-p53-glycolysis Axis[J]. Current Biotechnology, 2026, 16(4): 979-989.
| 基因 | 引物序列(5'→3') |
|---|---|
| CDCA8 | F: 5'-TCCTCGTCCCTACCCAGTTT-3' R: 5'-GCCTCCGTAAGGAGTTGGTC-3' |
| p53 | F: 5'-GCGCACAGAGGAAGAGAATC-3' R: 5'-GGCCAACTTGTTCAGTGGAG-3' |
| HK2 | F: 5'-GGGAGGTCTCCACTGAGGAT-3' R: 5'-ACGTACAACTGACCATTCATTACA-3' |
| PKM2 | F: 5'-CCTGATAGCTCGTGAGGCTG-3' R: 5'-AGGCTCGCACAAGTTCTTCA-3' |
| GLUT1 | F: 5'-AATGGTTCCATGCCTGAGGG-3' R: 5'-AAGGCAAGTGTCTCGACAGG-3' |
| β-actin | F: 5'-GGACTTCGAGCAAGAGATGG-3' R: 5'-ACATCTGCTGGAAGGTGGAC-3' |
Table 1 Primer sequences
| 基因 | 引物序列(5'→3') |
|---|---|
| CDCA8 | F: 5'-TCCTCGTCCCTACCCAGTTT-3' R: 5'-GCCTCCGTAAGGAGTTGGTC-3' |
| p53 | F: 5'-GCGCACAGAGGAAGAGAATC-3' R: 5'-GGCCAACTTGTTCAGTGGAG-3' |
| HK2 | F: 5'-GGGAGGTCTCCACTGAGGAT-3' R: 5'-ACGTACAACTGACCATTCATTACA-3' |
| PKM2 | F: 5'-CCTGATAGCTCGTGAGGCTG-3' R: 5'-AGGCTCGCACAAGTTCTTCA-3' |
| GLUT1 | F: 5'-AATGGTTCCATGCCTGAGGG-3' R: 5'-AAGGCAAGTGTCTCGACAGG-3' |
| β-actin | F: 5'-GGACTTCGAGCAAGAGATGG-3' R: 5'-ACATCTGCTGGAAGGTGGAC-3' |
| [1] | OLIVER A L. Lung cancer: epidemiology and screening[J]. Surg. Clin. North Am., 2022, 102(3): 335-344. |
| [2] | 罗添乐,罗斌,田建辉.中医药防治肺癌的理论研究进展[J].中医肿瘤学杂志,2019,1(2):1-6. |
| LUO T L, LUO B, TIAN J H. Advances in theoretical research on prevention and treatment of lung cancer with traditional Chinese medicine[J]. J. Oncol. Chin. Med., 2019, 1(2): 1-6. | |
| [3] | 陈浩方,雷旭东,党会芬,等.中医专方治疗肺癌用药规律研究[J].甘肃医药,2022,41(2):134-136. |
| CHEN H F, LEI X D, DANG H F, et al.. The study of the law of drug use for the treatment of lung cancer by Chinese medicine[J]. Gansu Med. J., 2022, 41(2): 134-136. | |
| [4] | 曾珠,何成诗,孙剑峰,等.白花蛇舌草对A549肺癌干细胞增殖、凋亡及细胞周期的影响[J].重庆医学,2019,48(13):2202-2205. |
| ZENG Z, HE C S, SUN J F, et al.. Effect of Hedyotis diffusa on proliferation, apoptosis and cell cycle of A549 lung cancer stem cells[J]. Chongqing Med., 2019, 48(13): 2202-2205. | |
| [5] | LIN J, LI Q, CHEN H, et al.. Hedyotis diffusa Willd. extract suppresses proliferation and induces apoptosis via IL-6-inducible STAT3 pathway inactivation in human colorectal cancer cells[J]. Oncol. Lett., 2015, 9(4): 1962-1970. |
| [6] | LI H, LAI Z, YANG H, et al.. Hedyotis diffusa Willd. inhibits VEGF-C-mediated lymphangiogenesis in colorectal cancer via multiple signaling pathways[J]. Oncol. Rep., 2019, 42(3): 1225-1236. |
| [7] | 高艳艳,王贵平,李春玲,等.白花蛇舌草提取物对肉鸡淋巴细胞增殖功能的影响[J].动物医学进展,2010,31(10):43-46. |
| GAO Y Y, WANG G P, LI C L, et al.. Effect of Oldenlandia extract on lymphocyte proliferation in chickens[J]. Prog. Vet. Med., 2010, 31(10): 43-46. | |
| [8] | 王雪,夏顺利,刘景楠,等.白花蛇舌草总黄酮大孔树脂纯化工艺及其体内抑瘤作用的研究[J].中医药信息,2021,38(3):16-21. |
| WANG X, XIA S L, LIU J N, et al.. Study on purification process of total flavonoids from Oldenlandia diffusa by macroporous resin and its tumor inhibition in vivo [J]. Inf. Tradit. Chin. Med., 2021, 38(3): 16-21. | |
| [9] | PENG B, ZHANG J, XIANG Y. CDCA8 and its multifaceted role in tumorigenesis[J/OL]. Biomed. Pharmacother., 2025, 185: 117951[2025-12-07]. . |
| [10] | GU H, GAO X, HAN W, et al.. Overexpression of CDCA8 predicts poor prognosis and drug insensitivity in lung adenocarcinoma[J/OL]. BMC Med. Genom., 2024, 17(1): 265[2025-12-07]. . |
| [11] | ZHOU Q, HUANG W, XIONG J, et al.. CDCA8 promotes bladder cancer survival by stabilizing HIF1α expression under hypoxia[J/OL]. Cell Death Dis., 2023, 14: 658[2025-12-07]. . |
| [12] | XIANG C, SUN W H, KE Y, et al.. CDCA8 contributes to the development and progression of thyroid cancer through regulating CDK1[J]. J. Cancer, 2022, 13(7): 2322-2335. |
| [13] | 罗悦,雒洪伟,姜星,等.基于转录组学探讨白花蛇舌草总黄酮抗肺癌A549细胞生长机制[J].药学研究,2023,42(11):857-864. |
| LUO Y, LUO H W, JIANG X, et al.. Transcriptomic study of total flavonoids of Hedyotis diffusa Willd. against the growth of lung cancer cells[J]. J. Pharm. Res., 2023, 42(11): 857-864. | |
| [14] | LEVINE A J. p53: 800 million years of evolution and 40 years of discovery[J]. Nat. Rev. Cancer, 2020, 20(8): 471-480. |
| [15] | LIU J, ZHANG C, HU W, et al.. Tumor suppressor p53 and metabolism[J]. J. Mol. Cell Biol., 2019, 11(4): 284-292. |
| [16] | LI X, WU L, ZOPP M, et al.. p53-TP53-induced glycolysis regulator mediated glycolytic suppression attenuates DNA damage and genomic instability in Fanconi anemia hematopoietic stem cells[J]. Stem Cells, 2019, 37(7): 937-947. |
| [17] | ZHANG C, LIU J, WU R, et al.. Tumor suppressor p53 negatively regulates glycolysis stimulated by hypoxia through its target RRAD[J]. Oncotarget, 2014, 5(14): 5535-5546. |
| [18] | KIM J, YU L, CHEN W, et al.. Willd-type p53 promotes cancer metabolic switch by inducing PUMA-dependent suppression of oxidative phosphorylation[J]. Cancer Cell, 2019, 35(2): 191-203. |
| [19] | LIU Y, GU W. The complexity of p53-mediated metabolic regulation in tumor suppression[J]. Semin. Cancer Biol., 2022, 85: 4-32. |
| [20] | HERNÁNDEZ-RESÉNDIZ I, GALLARDO-PÉREZ J C, LÓPEZ-MACAY A, et al.. Mutant p53R248Q downregulates oxidative phosphorylation and upregulates glycolysis under normoxia and hypoxia in human cervix cancer cells[J]. J. Cell. Physiol., 2019, 234(5): 5524-5536. |
| [21] | HANAHAN D, WEINBERG R A. Hallmarks of cancer: the next generation[J]. Cell, 2011, 144(5): 646-674. |
| [22] | VANDER HEIDEN M G, CANTLEY L C, THOMPSON C B. Understanding the Warburg effect: the metabolic requirements of cell proliferation[J]. Science, 2009, 324(5930): 1029-1033. |
| [23] | 王彩虹,陈剑飞,鞠久君,等.PKM2促进肿瘤发展的作用机制研究[J].生物技术进展,2022,12(3):411-418. |
| WANG C H, CHEN J F, JU J J, et al.. The mechanisms of PKM2 promoting tumor progression[J]. Curr. Biotechnol., 2022, 12(3): 411-418. | |
| [24] | HUANG F, PANG J, XU L, et al.. Hedyotis diffusa injection induces ferroptosis via the Ba x /Bcl2/VDAC2/3 axis in lung adenocarcinoma[J/OL]. Phytomedicine, 2022, 104: 154319[2025-12-07]. . |
| [25] | 李佳林.白花蛇舌草总黄酮联合顺铂对肺癌A549细胞增殖、凋亡的影响及可能机制[D].衡阳:南华大学,2018. |
| [26] | 孙晓春,郭佳宸,孙琛,等.桔梗、白花蛇舌草不同组分对人肺癌细胞A549的抑制作用[J].中国农学通报,2019,35(1):144-148. |
| SUN X C, GUOJIA C, SUN C, et al.. The inhibitory effect of extracts from Platycodon grandiflorum and Hedyotis diffusa willd on human lung cancer cells A549[J]. Chin. Agric. Sci. Bull., 2019, 35(1): 144-148. |
| [1] | Hongfei LIU, Wen ZHAO, Huiying YANG. ALKBH5 Affects Cisplatin Chemosensitivity in Non-small Cell Lung Cancer by Regulating CPNE1 m6A Methylation [J]. Current Biotechnology, 2026, 16(2): 412-421. |
| [2] | Yanjie WANG, Bo QIU. The Role and Research Progress of Gene P53 in Osteosarcoma [J]. Current Biotechnology, 2025, 15(2): 241-246. |
| [3] | Xuan ZHAO, Limei REN, Xiaoru WANG, Guangxin HAN, Dandan GU, Yasen YAO, Yonghao QI. Effects of siRNA Targeting to Interfere with the Expression of TRAF6 on the Proliferation and Apoptosis of Lung Cancer Cells [J]. Current Biotechnology, 2024, 14(5): 875-881. |
| [4] | Qianting YANG, Xiaoying TIAN, Junfang ZHANG, Bingshe HAN. Effect of tp53 Knockout on High Temperature Tolerance and Swimming Capacity in Zebrafish [J]. Current Biotechnology, 2023, 13(4): 580-587. |
| [5] | Jian DU, Zhigang TIAN, Hua LIN, Keliang XIE. Effect of Hydrogen Inhalation on Postoperative Delirium in Patients Undergoing Radical Surgery for Lung Cancer [J]. Current Biotechnology, 2022, 12(4): 510-515. |
| [6] | LI Fangfang, MU Dengcai,YANG Chunyan, WANG Lei, SHEN Hao, ZHENG Shangyong*. Expression and Function of KIF26B in the Development of Non-small Cell Lung Cancer [J]. Curr. Biotech., 2020, 10(3): 273-283. |
| [7] | ZHANG Haitao, ZHANG Yuxin*. miR-148a Inhibits Glycolysis and Cell Proliferation of Breast Cancer Cells Through Targeted Regulation of Hexokinase 2 Gene [J]. Curr. Biotech., 2020, 10(2): 176-184. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||